Alchemy Issue 36

MIPS researchers in the lab
Cover story

Our research translated: Discoveries with real-world impact

Monash’s vision of being the world’s leading academic institution when it comes to pharmacy and pharmaceutical sciences means its ambitions extend well beyond the classroom or laboratory. Instead, it sees the commercialisation and translation of its discoveries into real-world solutions, as an essential part of its mission.

Read more

Expanding ambitions: Monash's CSIRO acquisition

MIPS is set to expand its capabilities and ambitions as it prepares to move into the newly acquired CSIRO facilities at Parkville.

The Neuromedicines Discovery Centre: Providing hope for patients with mental health conditions

The NDC aims to create innovations in mental health treatments.

MedChem Australia: Creating drug candidates with commercial potential

MedChem Australia aims to translate drug research into proven treatments with commercial opportunities.

News in brief

Catch up on some of our faculty's biggest news stories from the past year.

  • Monash ranks #2 in the world

    for Pharmacy and Pharmacology in the 2023 QS World University Rankings by Subject.

    Read more

  • New website launched

    dedicated to the Monash Institute of Pharmaceutical Sciences (MIPS).

    Read more

  • Associate Professor Louis Roller AM

    has been appointed a Member of the Order of Australia.

    Read more

  • Staff recognition and awards

    Learn more about those whose contributions were recognised this year.

    Read more

Research with impact

Here are some of the research stories that emerged over the past year.

Increasing dairy intake for aged care residents helps reduce risk of fractures and could save up to $66 million in healthcare costs

New discovery: dual acting drug delivers blood cancer a lethal ‘one-two’ punch

Epilepsy register helps deliver healthy babies, huge savings, finds Monash study

Global study finds pharmacology education must focus on 25 core concepts

World first Monash-led study unlocks key new information on major drug target for psychiatric and cognitive disorders, including schizophrenia

Neuroscience and Mental Health

More high-quality evidence needed to address misinformation and reduce fears towards psychedelics to treat mental health conditions

Neuroscience and Mental Health

Scientists uncover new and “unexpected” information about schizophrenia drug

Neuroscience and Mental Health

New study finds medication to treat type 2 diabetes is more likely to reduce major cardiovascular events in men than women

Cardiovascular and Metabolic Health

Are Australians living with dementia overtreated for diabetes?

Cardiovascular and Metabolic Health

New discovery for treatment of primary liver cancer

Cardiovascular and Metabolic Health

Clinical trial of inhaled oxytocin to reduce maternal mortality underway in Melbourne

Global Health

Honour Roll

See our 1992–2023 Honour Roll of Donors and find out how you can leave a lasting legacy by supporting our faculty.

Alchemy is produced by the Development Office, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University
Managing Editor: Rachel Ung · Writers: Emma Sorensen, Ralph Grayden, Karen Boalch, Karen Gee, Kate Carthew and Larissa Ham
Photography: Ryan Wheatley, Melissa Cowan, Kelli Morris · Research and distribution: Marian Simkin · Web: Amy Chen
Disclaimer: Views expressed in Alchemy are those of the authors and persons quoted and are not necessarily those of the Monash Faculty of Pharmacy and Pharmaceutical Sciences, Monash University.